• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

OGDEN MANUFACTURING PLANT OPTIFLUX 160NRE DIALYZER FINISHED ASSY.; DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM Back to Search Results
Model Number 0500316E
Device Problem Fluid/Blood Leak (1250)
Patient Problems Blood Loss (2597); No Known Impact Or Consequence To Patient (2692)
Event Date 12/29/2019
Event Type  malfunction  
Manufacturer Narrative
The plant investigation is in process.A supplemental mdr will be submitted upon completion of this activity. .
 
Event Description
A user facility reported that an external dialyzer blood leak occurred during a patient¿s hemodialysis (hd) treatment.The blood leak was visually observed on unspecified are of the dialyzer.A blood test strip was used to test for the presence of blood, and the result was negative.It was confirmed that the machine, a fresenius 2008 k , alarmed appropriately with a blood leak alert.Fresenius bloodlines were used for the treatment.No damage was identified on the dialyzer.After the machine alarmed, the treatment was halted.The patient¿s blood was not returned; the estimated blood loss (ebl) was not captured in the clinic¿s incident report.Follow-up with the clinic¿s charge nurse confirmed there was no patient injury, no adverse events, and no medical intervention as a result of the reported event.The patient completed their treatment after being re-setup with new supplies on a different machine.The dialyzer was not available to be returned for evaluation as it was reportedly discarded.
 
Manufacturer Narrative
Corrected information: h2, h6 patient code- inadvertently omitted h2 for the correction on supplemental #2 (transcription error).
 
Manufacturer Narrative
Plant investigation: the reported complaint was not confirmed as the complaint device was not returned for manufacturer evaluation.A production records review was performed on the reported lot.An investigation of the device history records (dhr) was conducted by the manufacturer.There was one approved temporary deviation notice (dn) reported on the lot which was unrelated to the complaint event.There was no indication of product nonacceptance, deviation, non-conformance, rework, labeling or process control failure during the manufacturing process which could be associated with the reported event.The lot met all release criteria.A definitive conclusion regarding the complaint incident cannot be reached without physical examination of the actual device.Therefore, the complaint is not confirmed.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OPTIFLUX 160NRE DIALYZER FINISHED ASSY.
Type of Device
DIALYZER, HIGH PERMEABILITY WITH OR WITHOUT SEALED DIALYSATE SYSTEM
Manufacturer (Section D)
OGDEN MANUFACTURING PLANT
director, site quality
475 west 13th street
ogden UT 84404
MDR Report Key10882273
MDR Text Key222628320
Report Number1713747-2020-00475
Device Sequence Number1
Product Code KDI
UDI-Device Identifier00840861100149
UDI-Public00840861100149
Combination Product (y/n)N
PMA/PMN Number
K002761
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,user faci
Type of Report Initial,Followup,Followup,Followup
Report Date 12/07/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date09/30/2022
Device Model Number0500316E
Device Catalogue Number0500316E
Device Lot Number19LU01018
Was Device Available for Evaluation? No
Device AgeMO
Initial Date Manufacturer Received 11/02/2020
Initial Date FDA Received11/22/2020
Supplement Dates Manufacturer Received11/23/2020
12/03/2020
12/04/2020
Supplement Dates FDA Received12/01/2020
12/04/2020
12/07/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Treatment
FRESENIUS 2008K MACHINE.; FRESENIUS BLOODLINE.
-
-